Dengue Vaccine Shows Favourable Safety Profile in Travellers from Non-Endemic Regions
A prospective study of more than 1,000 people vaccinated with TAK-003 in Catalonia found no serious adverse events and provides new evidence on the...
A prospective study of more than 1,000 people vaccinated with TAK-003 in Catalonia found no serious adverse events and provides new evidence on the...
The IDIBAPS Steering Committee approved in 2025 the creation of the new research group Translational oncology of upper gastrointestinal cancer. The...
For decades, stroke has been mainly associated with older adults. However, recent studies highlight a concerning rise in cases among younger adults...
A study led by the Pathogenesis of autoimmune neuronal disorders research group at IDIBAPS provides new evidence on the long-term evolution of pat...
Dr. Miquel Lozano Molero has been appointed President of the World Apheresis Association (WAA) for the 2026–2028 term. The election took place duri...
The agreement with a specialist company will enable more accurate and faster diagnoses for patients with multiple sclerosis and drive new developme...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...
From June 1 to July 24, 2026, participants will be able to submit their project or innovative idea to either of the two programs of Campus Clínic I...
This European recognition endorses centres that integrate cancer care, research, education and innovation under the most demanding quality standards.
This May marks the 25th anniversary of the creation of the Functional Genomics Core Facility at IDIBAPS. The platform provides researchers with acc...